Image Results

TARCEVA Pages on BioPortfolio:

Biotechnology News TARCEVA Search
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic .... ODAC will Review Tarceva for Maintenance Therapy in Advanced Non-Small Cell ...
http://www.bioportfolio.co.uk/TARCEVA-news.htm...

Combining Avastin and Tarceva as a synergistic approach to cancer?
The development of Avastin (bevacizumab) and Tarceva are promising to improve this situation as well as offering hope to other patients with diverse cancers
...
http://www.bioportfolio.com/LeadDiscovery/PubMed-030511.html...

Biotechnology News pancreatic cancer Search
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Ad ...
http://www.bioportfolio.co.uk/pancreatic%20cancer-news.htm...

BioPortfolio - Tarceva
Tarceva - BioPortfolio - Indepth. ... Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
...
http://www.bioportfolio.com/indepth/Tarceva.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - TARCEVA - Profile
Therapeutics Daily: Nov 5 2009 3:23PM Matching: tarceva ... Forbes.com via MSN Money: Oct 26 2009 3:30PM Matching: tarceva ...
http://www.bioportfolio.com/biocorporate/30779-TARCEVA.pdf...

Biotechnology News FDA EMEA CDER regulatory vandetanib. zactima ...
Mounting evidence indicates that tyrosine kinase inhibitors (TKIs), such as erlotinib (Tarceva, Genentech) and gefitinib (Iressa, AstraZeneca), ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - BioPortfolio - TARCEVA
BioPortfolio - TARCEVA - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/30779/www.t...

Pipeline Insight: Cancer Overview - Gastrointestinal, Skin, Sarcomas
19 Dec 2008 ... If this can be replicated in Phase III trials, approval is likely, given that Tarceva was approved based on a 2-week survival benefit. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Pipeline_Insigh...

BioPortfolio - OSI Pharmaceuticals - Profile
30 Oct 2009 ... Behind Tarceva, we have an emerging oncology pipeline of molecular ... Our Flagship Product Tarceva (erlotinib) is a small molecule ...
http://www.bioportfolio.com/biocorporate/7940-OSI%2525252525...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Tarceva
Tarceva is a selective and orally active inhibitor of the Epidermal Growth Factor Receptor (EGFR), tyrosine kinase, that is associated with the aberrant
...
http://www.gene.com/gene/products/information/oncology/tarce...

Erlotinib - Wikipedia, the free encyclopedia
In November 2008 a study undertaken by Roche Holding of Switzerland claimed that Tarceva given immediately ...
http://en.wikipedia.org/wiki/Erlotinib...

Genentech: Pipeline: Tarceva
Skip to Content for Tarceva Menu for Tarceva About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu ...
http://www.gene.com/gene/pipeline/status/oncology/tarceva/...

FINAL 30April 2009 PI-Clean
TARCEVA safely and effectively. See full prescribing information for .... showed no clinical benefit with the concurrent administration of TARCEVA with ...
http://www.osip.com/full_PI_tarceva...

Genentech: Medicines: Tarceva Fact Sheet
Skip to Content for Tarceva Fact Sheet Menu for Tarceva Fact Sheet About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu ...
http://www.gene.com/gene/products/information/oncology/tarce...

Tarceva (erlotinib) Tablets NDA 21-743, S003 Supplemental NDA ...
Tarceva (erlotinib) received full approval in the US by the FDA on 18 November 2004 ... The focus of this Supplemental NDA is on the use of Tarceva in ...
http://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4174B1_...

Genentech: Investors: Tarceva - Historical Sales
Skip to Content for Tarceva - Historical Sales Menu for Tarceva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/tarceva.ht...

ACS :: Tarceva Approved for Lung Cancer
19 Nov 2004 ... Patients with the most common type of lung cancer now have another treatment option: erlotinib (marketed as Tarceva).
http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Tarceva_A...

Tarceva® (erlotinib) tablets
Tarceva® (erlotinib) is a small molecule human epidermal growth factor type 1/ epidermal growth factor receptor (HER1/EGFR) inhibitor which is currently ...
http://www.osip.com/tarceva...

The current situation: erlotinib (Tarceva) and gefitinib (Iressa ...
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer. Comis RL. Drexel University College of Medicine, ...
http://www.ncbi.nlm.nih.gov/pubmed/16079313...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.